RAPT Therapeutics and Jemincare Pharmaceutical Sign an Exclusive License Agreement to Develop JYB1904 (RPT904)
Shots: Agreement grants global (excl. mainland China, Hong Kong, Macau & Taiwa...
Astellas and Sangamo Therapeutics Partner for Administering Genomic Therapies Targeting Neurological Disorders
Shots: Sangamo licensed the global rights for the use of STAC-BBB capsid (has depi...
BioArctic Collaborates with BMS for its Pyroglutamate-Amyloid-Beta Antibody Programs
Shots: BioArctic & BMS have signed a global exclusive license agreement t...
Merck Join Forces with Hansoh Pharma to Develop HS-10535
Shots: Merck and Hansoh Pharma have signed an exclusive worldwide licensing agreem...
Abilita Therapeutics and Orion Collaborate to Advance Antibodies Development in Oncology and Pain
Shots: Abilita and Orion entered into a global license and multi-target research c...
Gilead and Terray Therapeutics Partner to Discover and Develop Small Molecules for Various Targets
Shots: Gilead Sciences and Terray Therapeutics have entered into a strategic colla...
